Randomized controlled trial to compare safety and efficacy of mycophenolate vs. cyclosporine after rituximab in children with steroid‐resistant nephrotic syndrome-Reference-Cited by-同舟云学术

Randomized controlled trial to compare safety and efficacy of mycophenolate vs. cyclosporine after rituximab in children with steroid‐resistant nephrotic syndrome

Published:2022-08-06 Issue:9 Volume:42 Page:690-696
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Assadi Farahnak¹^ORCID,Mazaheri Mojgan²,Sadeghi‐Bodj Simin³

Affiliation:

1. Division of Nephrology, Department of Pediatrics Rush University Medical Center Chicago Illinois USA

2. Section of Nephrology, Department of Pediatrics Semnan University of Medical Science Semnan Iran

3. Division of Nephrology, Department of Pediatrics Zahedan University of Medical Sciences Zahedan Iran

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2721

Reference28 articles.

1. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome

2. Steroid‐resistant nephrotic syndrome in children;Kidney Disease Improving Global Outcome (KDIGO);Kidney Int Suppl,2021

3. Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome

4. Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome

5. Effective and safe treatment with cyclosporine in nephrotic children: A prospective, randomized multicenter trial

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review and Meta-analysis of Rituximab-Associated Infections Among Children and Adolescents With Glomerular Disease: Focus on the Risk of Infections;The Journal of Pediatric Pharmacology and Therapeutics;2023-08-01

2. A novel prednisone premedication protocol significantly decreases infusion‑related reactions of rituximab in newly diagnosed diffuse large B‑cell lymphoma;Oncology Letters;2023-04-28

3. Tacrolimus Compared with Other Immunosuppressants in Children with Refractory Nephrotic Syndrome;Advances in Clinical Medicine;2023